Biontech

A significant rollout of Covid-19 vaccines is unlikely to happen before the middle of next year and priority will initially be given to protecting vul(...)

As promising results are released from a second vaccine trial, we take a look at what this could mean in the battle against Covid-19. What’s happened(...)

The announcement by pharmaceutical company Pfizer and tech company BioNTech that their coronavirus vaccine works to prevent Covid-19 has been welcomed(...)

The daily toll of new infections. The number of hospitalisations. The numbers in ICU. The R-0 number. The cases per 100,000 people. For more than eigh(...)

Image of the week: Hyperloop express Taking a provisional silver medal for breakthrough of the week, Virgin Hyperloop spent its Sunday sending its fi(...)

The Covid-19 pandemic has produced a level of cross-border collaboration that was once unimaginable. Barriers to international co-operation have come (...)

Reporting on Europe can be a cacophonous experience. On a typical day, Covid-19 news will compete with Brexit developments, against international geop(...)

The EU has agreed to buy up to 300 million doses of the groundbreaking coronavirus vaccine developed by BioNTech and Pfizer, following widespread hope(...)

Irish banks are well prepared to deal with a spike in non-performing loans next year when the effect of payment breaks wear off, according to analysts(...)

Stormont ministers have again failed to agree fresh coronavirus restrictions for Northern Ireland amid fraying relations at the top of the powersharin(...)